Sparsentan: Sparsentan- A Novel, Non- Immunosuppressive, Dual Action Angiotensin II and Endothelin A Receptor Antagonist -A New Hope for Glomerular Disease. J Shaheed Suhrawardy Med Coll 2024, 14 (2), 58-62. https://doi.org/10.3329/jssmc.v14i2.73180.